A lot of nice theories however regardless of how the company's share price and marketcap is treated in a transitioning period, when revenues and profits start rolling in and the company has to start rewarding investors with dividends, the company can no longer be ignored. Equilibrium eventually ensures that the marketcap synchronises with the dividend return percentage-wise.
I don't think AJX is being ignored by the way, it really does have a very healthy marketcap, $240mill is not typically speculative punt material.
- Forums
- Charts
- New week early reads
A lot of nice theories however regardless of how the company's...
Featured News
Add AJX (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.73M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.0¢ | $17.32K | 1.728M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1535720 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 6314 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1535720 | 0.010 |
6 | 519629 | 0.009 |
3 | 511000 | 0.008 |
2 | 240000 | 0.007 |
3 | 516888 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 6314 | 2 |
0.014 | 137511 | 2 |
0.015 | 129929 | 2 |
0.016 | 5328505 | 2 |
0.017 | 321118 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AJX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online